Quarterly report pursuant to Section 13 or 15(d)

NOTE 1 - DESCRIPTION OF BUSINESS & SUMMARY OF ACCTING POLICIES (Details Narrative)

v3.5.0.2
NOTE 1 - DESCRIPTION OF BUSINESS & SUMMARY OF ACCTING POLICIES (Details Narrative)
Sep. 29, 2014
USD ($)
$ / shares
Notes to Financial Statements  
Purchase price, shares $ 31,954,236
Registrant's common stock at price per share (I) 0.15
Registrant's common stock at price per share (II) $ 0.35
Percentage of MariMed's outstanding equity 49
Common stock fair value | $ $ 5,911,534
Common stock fair value price per share $ 0.185
Percentag of stock option fair value measured by the Black-Sholes valuation model | $ $ 569,682
Risk free interest - percentage 1.56
Dividend yield - percentage 0.00%
Volatility - percentage 311